The New England journal of medicine
-
Comment Letter Meta Analysis
Hypofractionated radiotherapy for breast cancer.
-
Historical Article
Tobacco product regulation--a public health approach.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points. ⋯ Everolimus-eluting stents, as compared with paclitaxel-eluting stents, resulted in reduced rates of target-lesion failure at 1 year, results that were consistent in all patients except those with diabetes, in whom the results were nonsignificantly different. (ClinicalTrials.gov number, NCT00307047.)